SAB-176
SAB-176-101
Phase 1 mab completed
Quick answer
SAB-176 for Influenza Type A is a Phase 1 program (mab) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SAB Biotherapeutics
- Indication
- Influenza Type A
- Phase
- Phase 1
- Modality
- mab
- Status
- completed